Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-000202-29Phase 2Completed
Phase 2, double-blind trial of ropivacaine and dexamethasone in tonsillar disease and postoperative pain (4 arms), sponsored by Centro Clínico Académico - Braga. Primary endpoint: Change in Visual Analogue Scale pain score at rest and during swallowing. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-000202-29.